Adagrasibu generic drug price in India

Adagrasib should be prescribed by physicians experienced in the use of anticancer drugs. Monotherapy is indicated for adult patients with KRAS G12C-mutated advanced non-small cell lung cancer (NSCLC) whose disease has progressed after at least one prior systemic therapy . It has the advantage of being effective in KRAS Objective response rate and duration of response in patients with G12C-mutated non-small cell lung cancer who had disease progression following prior therapy.

Adagrasiib is available as 200 mg film-coated tablets. The active substance of adagrasib is adagrasib, a KRAS G12C (Kirsten rat sarcoma viral oncogene homolog) inhibitor (ATC ode) that covalently and irreversibly binds to the unique cysteine u200bu200bof KRAS G12C. In tumors containing KRAS G12C, an oncogenic driver of tumorigenesis, inactivation of KRAS G12C by adagrasib blocks tumor cell signaling and survival, inhibits cell growth and selectively promotes apoptosis. The most common side effects of adagrasib are diarrhea, nausea, vomiting, fatigue, liver toxicity, and anemia.

Sinceadagrasibthe original drug has not yet been launched in China, patients can only purchase adagrasib through overseas channels, and the U.S. original version of 200mg*180 tablets is priced at hundreds of thousands of yuan per box (the price may fluctuate due to exchange rates), which is very expensive. Currently, there are no generic drugs of adagrasib produced overseas, so there is no information and prices for Indian generic drugs. For more drug information and specific prices, please consult Yaode’s medical consultant.